Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Calvert H, Boddy AV, Hollema H, Féty R, Van der Vijgh WJ, Hempel G, Chatelut E, Karlsson M, Wilkins J, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH. Joerger M, et al. Among authors: hempel g. Clin Cancer Res. 2007 Nov 1;13(21):6410-8. doi: 10.1158/1078-0432.CCR-07-0064. Clin Cancer Res. 2007. PMID: 17975154
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.
Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Féty R, de Bruijn E, Hempel G, Karlsson M, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH; EORTC-PAMM-NDDG. Joerger M, et al. Among authors: hempel g. Clin Pharmacokinet. 2007;46(12):1051-68. doi: 10.2165/00003088-200746120-00005. Clin Pharmacokinet. 2007. PMID: 18027989 Clinical Trial.
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer.
Völler S, Boos J, Krischke M, Würthwein G, Kontny NE, Boddy AV, Hempel G. Völler S, et al. Among authors: hempel g. Clin Pharmacokinet. 2015 Nov;54(11):1139-49. doi: 10.1007/s40262-015-0272-4. Clin Pharmacokinet. 2015. PMID: 25925711 Clinical Trial.
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial.
Krischke M, Hempel G, Völler S, André N, D'Incalci M, Bisogno G, Köpcke W, Borowski M, Herold R, Boddy AV, Boos J. Krischke M, et al. Among authors: hempel g. Cancer Chemother Pharmacol. 2016 Dec;78(6):1175-1184. doi: 10.1007/s00280-016-3174-8. Epub 2016 Oct 21. Cancer Chemother Pharmacol. 2016. PMID: 27770238 Free PMC article. Clinical Trial.
Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) Trial.
Hellmann F, Völler S, Krischke M, Jamieson D, André N, Bisogno G, Boddy A, Hempel G. Hellmann F, et al. Among authors: hempel g. Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):413-422. doi: 10.1007/s13318-019-00592-6. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31981210 Clinical Trial.
Towards a Model-Based Dose Recommendation for Doxorubicin in Children.
Völler S, Hempel G, Würthwein G, Boddy AV, Krischke M, André N, D'Incalci M, Bisogno G, Boos J. Völler S, et al. Among authors: hempel g. Clin Pharmacokinet. 2017 Mar;56(3):215-223. doi: 10.1007/s40262-016-0451-y. Clin Pharmacokinet. 2017. PMID: 27641152 Free PMC article. Clinical Trial.
266 results